Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PFBX
|
Joseph Stilwell |
BUY
Open market or private purchase
|
Indirect | 2,235 Added 0.0% |
$42,912
$19.2 p/Share
|
Apr 09
2025 |
|
PLAB
|
Walter M Fiederowicz |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 28.52% |
$132,160
$18.88 p/Share
|
Apr 09
2025 |
|
CNFR
|
James Grant Smith |
BUY
Open market or private purchase
|
Direct | 16,000 Added 50.0% |
$10,880
$0.68 p/Share
|
Apr 09
2025 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 918 Added 0.0% |
$2,129
$2.32 p/Share
|
Apr 09
2025 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Direct | 356 Added 0.49% |
$825
$2.32 p/Share
|
Apr 09
2025 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.04% |
$3,311
$1103.71 p/Share
|
Apr 09
2025 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 9 Added 0.0% |
$9,918
$1102.1 p/Share
|
Apr 09
2025 |
|
Ctth
|
Ctt Pharmaceutical Holdings, Inc.
CEO |
BUY
Open market or private purchase
|
Direct | 9,984 Added 0.15% |
$599
$0.06 p/Share
|
Apr 09
2025 |
|
JFR
|
Scott C. Caraher |
BUY
Open market or private purchase
|
Direct | 5,000 Added 9.91% |
$39,750
$7.95 p/Share
|
Apr 09
2025 |
|
SCYX
|
Gonzalez David Angulo
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 23,000 Added 2.74% |
$19,320
$0.84 p/Share
|
Apr 09
2025 |
|
SCTC
|
Y.D. More Investments LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 650 Reduced 0.0% |
$3,815
$5.87 p/Share
|
Apr 09
2025 |
|
RNXT
|
Shaun Bagai
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 10,000 Added 3.1% |
$8,300
$0.83 p/Share
|
Apr 09
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 78,522 Reduced 0.83% |
$868,453
$11.06 p/Share
|
Apr 09
2025 |
|
CDXC
|
Robert N Fried
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 66,667 Added 6.03% |
$220,001
$3.3 p/Share
|
Apr 09
2025 |
|
PLMR
|
T Christopher Uchida
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 9.83% |
$144,000
$144.0 p/Share
|
Apr 09
2025 |
|
LGF-B
|
Liberty 77 Capital L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 310,535 Added 0.0% |
$2,052,636
$6.61 p/Share
|
Apr 09
2025 |
|
RBRK
|
Arvind Nithrakashyap
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 32,484 Reduced 21.05% |
$1,884,396
$58.01 p/Share
|
Apr 09
2025 |
|
GRPH
|
Shawn Olsson
Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,400 Added 22.83% |
$2,912
$2.08 p/Share
|
Apr 09
2025 |
|
FLWS
|
Fund 1 Investments, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 30,000 Added 0.0% |
$171,300
$5.71 p/Share
|
Apr 09
2025 |
|
BRK-A
|
Buffett Warren E
Chairman and CEO |
SELL
Bona fide gift
|
Direct | 160 Reduced 16.82% |
-
|
Apr 09
2025 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 0.0% |
$118,800
$5.94 p/Share
|
Apr 09
2025 |
|
CVNA
|
Benjamin E. Huston
Chief Operating Officer |
BUY
Conversion of derivative security
|
Direct | 26,710 Added 15.07% |
-
|
Apr 09
2025 |
|
BTCS
|
Charles W Allen
CEO |
SELL
Open market or private sale
|
Direct | 65,000 Reduced 1.53% |
$93,600
$1.44 p/Share
|
Apr 09
2025 |
|
UYSC
|
Uy Scuti Investments LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 7,090 Added 0.42% |
$70,900
$10.0 p/Share
|
Apr 09
2025 |
|
ATSG
|
Matthew E. Fedders
VP, Controller |
SELL
Bona fide gift
|
Direct | 1,600 Reduced 2.85% |
$35,984
$22.49 p/Share
|
Apr 09
2025 |
|
BUKS
|
Joseph Patrick Daly
Director |
BUY
Open market or private purchase
|
Direct | 5,089 Added 0.12% |
$7,328
$1.44 p/Share
|
Apr 09
2025 |
|
SHIM
|
Mitchell B. Goldsteen |
SELL
Open market or private sale
|
Indirect | 4,675 Reduced 0.0% |
$6,358
$1.36 p/Share
|
Apr 09
2025 |
|
SMRT
|
Robyn Young
Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,099 Added 3.24% |
-
|
Apr 09
2025 |
|
SMRT
|
Robyn Young
Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 879 Reduced 1.4% |
$905
$1.03 p/Share
|
Apr 09
2025 |
|
JOBY
|
Didier Papadopoulos
President of Aircraft OEM |
SELL
Open market or private sale
|
Direct | 3,132 Reduced 3.98% |
$18,165
$5.8 p/Share
|
Apr 09
2025 |
|
JOBY
|
Gregory Bowles
Officer |
SELL
Open market or private sale
|
Direct | 9,848 Reduced 6.04% |
$56,724
$5.76 p/Share
|
Apr 09
2025 |
|
LQDT
|
Jaime Mateus Tique |
SELL
Open market or private sale
|
Indirect | 931 Reduced 0.0% |
$27,399
$29.43 p/Share
|
Apr 09
2025 |
|
CDLX
|
Liane Hornsey
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,326 Added 10.48% |
-
|
Apr 09
2025 |
|
ASPS
|
Gregory J. Ritts
Chief Legal/Compliance Officer |
BUY
Open market or private purchase
|
Direct | 20,000 Added 6.85% |
$9,600
$0.48 p/Share
|
Apr 09
2025 |
|
NBY
|
Poplar Point Capital Partners LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 300 Added 0.03% |
$138
$0.46 p/Share
|
Apr 08
2025 |
|
VLGEA
|
Robert Sumas
Director |
SELL
Open market or private sale
|
Direct | 943 Reduced 0.99% |
$34,146
$36.21 p/Share
|
Apr 08
2025 |
|
NXDT
|
James D Dondero
Director |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 0.0% |
$408,000
$4.08 p/Share
|
Apr 08
2025 |
|
NUTX
|
Jon Christian Bates
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 1,000 Added 16.98% |
$81,810
$81.81 p/Share
|
Apr 08
2025 |
|
GAM-PB
|
Trust Fbo Altschul Arthur G Jr Uw Altschul Frank |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 100.0% |
$49,240
$24.62 p/Share
|
Apr 08
2025 |
|
GAM-PB
|
Arthur G Altschul Jr
Director |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$49,240
$24.62 p/Share
|
Apr 08
2025 |
|
EVCM
|
Eric Richard Remer
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 16,351 Reduced 0.0% |
$155,007
$9.48 p/Share
|
Apr 08
2025 |
|
ZM
|
Aparna Bawa
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Indirect | 10,864 Reduced 0.0% |
$739,295
$68.05 p/Share
|
Apr 08
2025 |
|
ZM
|
Aparna Bawa
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Indirect | 21,392 Added 0.0% |
-
|
Apr 08
2025 |
|
OMI
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 105,000 Added 0.0% |
$835,800
$7.96 p/Share
|
Apr 08
2025 |
|
ZM
|
Eric S. Yuan
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Indirect | 34,762 Reduced 0.0% |
$2,365,554
$68.05 p/Share
|
Apr 08
2025 |
|
ZM
|
Eric S. Yuan
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect | 68,455 Added 0.0% |
-
|
Apr 08
2025 |
|
NYC
|
Nicholas S Schorsch
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,661 Added 0.0% |
$19,466
$11.72 p/Share
|
Apr 08
2025 |
|
SBGI
|
David D Smith
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 122,072 Added 7.7% |
$1,667,503
$13.66 p/Share
|
Apr 08
2025 |
|
PHR
|
David Linetsky
SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect | 248 Reduced 0.0% |
$5,944
$23.97 p/Share
|
Apr 08
2025 |
|
PHR
|
David Linetsky
SVP, Life Sciences |
SELL
Open market or private sale
|
Direct | 3,944 Reduced 1.75% |
$94,537
$23.97 p/Share
|
Apr 08
2025 |